AzTrials
AzTrials

Emotional and Behavioral Disorders in Children and AdolescentsNCT06900465

Pilot Evaluation of a Psychoeducation Group for Family Caregivers of Children and Adolescents With Emotional and Behavioral Disorders (CPG-CA) in China

A study testing Caregiver Psychoeducation Group for Children and Adolescents with Emotional and Behavioral Disorders (CPG-CA) in people with Emotional and Behavioral Disorders in Children and Adolescents, run by Shanghai Mental Health Center at 1 site in China.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this waitlist-controlled randomized pilot trial is to premilinariliy learn if the CPG-CA internvention, a group psychoeducational intervention for family caregivers of children and adolescents with emotional and behavioral disorders, works to relieve caregiver burden among family caregivers of children and… Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Caregiver Psychoeducation Group for Children and Adolescents with Emotional and Behavioral Disorders (CPG-CA)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteChina
Study dates
1 Jun 2025to 30 Apr 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Family caregivers of children and adolescents under the age of 18 with emotional and behavioral disorders;
  • The child or adolescent must have a confirmed diagnosis of an emotional or behavioral disorder, including: emotional and behavioral disorders with onset usually occurring in childhood and adolescence, mood disorders, depressive disorders, bipolar disorder, anxiety disorders, attention-deficit/hyperactivity disorder (ADHD), conduct disorder, oppositional defiant disorder, obsessive-compulsive disorder (OCD), eating disorders, schizophrenia, and addictive disorders;
  • Providing care for a child or adolescent with an emotional or behavioral disorder for at least three months;
  • Aged 18 or older;
  • Able to provide informed consent.

Who cannot join

  • Caregivers of children and adolescents with neurodevelopmental disorders (e.g., autism, intellectual disability);
  • Paid caregivers;
  • Caregivers with severe physical illnesses or mental disorders;
  • Caregivers under the age of 18;
  • Those unable to provide informed consent;
  • Caregivers who are simultaneously participating in other support groups for family caregivers of children and adolescents with emotional and behavioral disorders.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Hao Yao, MD, MPH contact

+86 18817301628

haoyao@vip.163.com

China1 site
  • Shanghai Mental Health Center

    Shanghai, Shanghai Municipality, 200030

    Hao Yao, MD, MPH, +86 18817301628, haoyao@vip.163.com

Other trials in China

About this study

The goal of this waitlist-controlled randomized pilot trial is to premilinariliy learn if the CPG-CA internvention, a group psychoeducational intervention for family caregivers of children and adolescents with emotional and behavioral disorders, works to relieve caregiver burden among family caregivers of children and adolescents with emotional and behavioral disorders in China. It will also learn about the acceptability of the CPG-CA intervention. The main questions it aims to answer are:

Does the CPG-CA intervention relieve caregiver burden among family caregivers of children and adolescents with emotional and behavioral disorders in China? Is the CPG-CA intervention acceptable to family caregivers of children and adolescents with emotional and behavioral disorders in China?

Read more

Researchers will compare the CPG-CA intervention to care-as-usual to see if the CPG-CA internvention works to relieve caregiver burden among family caregivers of children and adolescents with emotional and behavioral disorders in China.

Participants will receive the CPG-CA intervention or care-as-usual for 12 weeks.

Read the detailed description

In China, most children and adolescents with emotional and behavioral disorders (E/BDs) are living with families. With an extreme scarcity of child and adolescent mental health care resources in China, the primary caregiving responsibility for children and adolescents with E/BDs is laid on families. However, caregiving for children and adolescents with E/BDs could be challenging, and family caregivers of children and adolescents with E/BDs often describe their caregiving experiences as exhausting and burdensome.

To date, very few interventions in China have been designed to relieve caregiver burden among family caregivers of children and adolescents with E/BDs. Therefore, this study aims to conduct a randomized, wait-list controlled pilot trial to preliminarily evaluate the feasibility and effectiveness of the CPG-CA intervention, a group psychoeducational intervention for family caregivers of children and adolescents with E/BDs, in reducing caregiver burden among family caregivers of children and adolescents with E/BDs in China. This pilot trial will lay the groundwork for a major trial that will be conducted in future studies.

Being tested
Caregiver Psychoeducation Group for Children and Adolescents with Emotional and Behavioral Disorders (CPG-CA)
Keywords
Pilot trial, Emotional and behavioral disorder, Child and adolescent, Psychoeducation, China, Psychosocial intervention, Caregiver
Medical subject headings
Mental Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Caregiver Psychoeducation Group for Children and Adolescents with Emotional and Behavioral Disorders (CPG-CA)Behavioural

    The CPG-CA intervention is a group psychoeducational internvention for family caregivers of children and adolescents with E/BDs in China. It will consist of 10 to 15 family caregivers of children and adolescents with E/BDs, meeting once a week for 1.5 to 2 hours per session, for a total of 12 sessions over a 3-month period. The sessions will cover the following themes: (1) knowledge about child and adolescent emotional and behavioral disorders; (2) coping skills for common emotional and behavioral problems in children and adolescents; (3) problem-solving skills; (4) communication skills with children and adolescents; (5) positive parenting techniques; and (6) self-care techniques. A variety of facilitation techniques will be used in the intervention, including didactic teaching, group discussion, role-playing, and homework assignment.

Study groups in NCT06900465
Study groupRoleWhat they receive
Intervention groupExperimentalThe intervention group will first receive the CPG-CA intervention.
Receives: Behavioral: Caregiver Psychoeducation Group for Children and Adolescents with Emotional and Behavioral Disorders (CPG-CA)
Waitlist control groupNo interventionThe waitlist control group will receive the CPG-CA intervention after the intervention group. During the waiting period, the waitlist control group will receive care as usual.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Caregiver burden

    Participants' caregiver burden will be assessed using the Zarit Burden Interview (ZBI).

    Measured: Baseline (T0) and 3 months (T1)

Secondary outcomes (29)
  1. Caregiver burden

    Participants' caregiver burden will be assessed using the Zarit Burden Interview (ZBI).

    Measured: Baseline (T0) and 6 months (T2)

  2. Caregiver burden

    Participants' caregiver burden will be assessed using the Zarit Burden Interview (ZBI).

    Measured: Baseline (T0) and 9 months (T3)

  3. Depression

    Participants' depression will be assessed using the Patient Health Questionnaire (PHQ).

    Measured: Baseline (T0) and 3 months (T1)

  4. Depression

    Participants' depression will be assessed using the Patient Health Questionnaire (PHQ).

    Measured: Baseline (T0) and 6 months (T2)

  5. Depression

    Participants' depression will be assessed using the Patient Health Questionnaire (PHQ).

    Measured: Baseline (T0) and 9 months (T3)

  6. Anxiety

    Participants' anxiety will be assessed using the Generalized Anxiety Disorder Scale (GAD).

    Measured: Baseline (T0) and 3 months (T1)

  7. Anxiety

    Participants' anxiety will be assessed using the Generalized Anxiety Disorder Scale (GAD).

    Measured: Baseline (T0) and 6 months (T2)

  8. Anxiety

    Participants' anxiety will be assessed using the Generalized Anxiety Disorder Scale (GAD).

    Measured: Baseline (T0) and 9 months (T3)

  9. Illness perception

    Participants' illness perception will be assessed using the Brief Illness Perception Questionnaire (BIPQ).

    Measured: Baseline (T0) and 3 months (T1)

  10. Illness perception

    Participants' illness perception will be assessed using the Brief Illness Perception Questionnaire (BIPQ).

    Measured: Baseline (T0) and 6 months (T2)

  11. Illness perception

    Participants' illness perception will be assessed using the Brief Illness Perception Questionnaire (BIPQ).

    Measured: Baseline (T0) and 9 months (T3)

  12. Coping style

    Participants' coping style will be assessed using the Simplified Coping Style Questionnaire (SCSQ).

    Measured: Baseline (T0) and 3 months (T1)

  13. Coping style

    Participants' coping style will be assessed using the Simplified Coping Style Questionnaire (SCSQ).

    Measured: Baseline (T0) and 6 months (T2)

  14. Coping style

    Participants' coping style will be assessed using the Simplified Coping Style Questionnaire (SCSQ).

    Measured: Baseline (T0) and 9 months (T3)

  15. Social support

    Participants' social support will be assessed using the Oslo Social Support Scale (OSSS).

    Measured: Baseline (T0) and 3 months (T1)

  16. Social support

    Participants' social support will be assessed using the Oslo Social Support Scale (OSSS).

    Measured: Baseline (T0) and 6 months (T2)

  17. Social support

    Participants' social support will be assessed using the Oslo Social Support Scale (OSSS).

    Measured: Baseline (T0) and 9 months (T3)

  18. Positive caregiving experiences

    Participants' positive caregiving experiences will be assessed using the Positive Aspect of Caregiving scale (PAC).

    Measured: Baseline (T0) and 3 months (T1)

  19. Positive caregiving experiences

    Participants' positive caregiving experiences will be assessed using the Positive Aspect of Caregiving scale (PAC).

    Measured: Baseline (T0) and 6 months (T2)

  20. Positive caregiving experiences

    Participants' positive caregiving experiences will be assessed using the Positive Aspect of Caregiving scale (PAC).

    Measured: Baseline (T0) and 9 months (T3)

  21. Feeling of hope

    Participants' feeling of hope will be assessed using the Herth Hope Index (HHI).

    Measured: Baseline (T0) and 3 months (T1)

  22. Feeling of hope

    Participants' feeling of hope will be assessed using the Herth Hope Index (HHI).

    Measured: Baseline (T0) and 6 months (T2)

  23. Feeling of hope

    Participants' feeling of hope will be assessed using the Herth Hope Index (HHI).

    Measured: Baseline (T0) and 9 months (T3)

  24. Feeling of mastery

    Participants' feeling of mastery will be assessed using the Pearlin Mastery Scale (PMS).

    Measured: Baseline (T0) and 3 months (T1)

  25. Feeling of mastery

    Participants' feeling of mastery will be assessed using the Pearlin Mastery Scale (PMS).

    Measured: Baseline (T0) and 6 months (T2)

  26. Feeling of mastery

    Participants' feeling of mastery will be assessed using the Pearlin Mastery Scale (PMS).

    Measured: Baseline (T0) and 9 months (T3)

  27. Self-stigma

    Participants' self-stigma will be assessed using the stigma sub-scale of the Experiences of Caregiving Inventory (ECI).

    Measured: Baseline (T0) and 3 months (T1)

  28. Self-stigma

    Participants' self-stigma will be assessed using the stigma sub-scale of the Experiences of Caregiving Inventory (ECI).

    Measured: Baseline (T0) and 6 months (T2)

  29. Self-stigma

    Participants' self-stigma will be assessed using the stigma sub-scale of the Experiences of Caregiving Inventory (ECI).

    Measured: Baseline (T0) and 9 months (T2)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Mar 2025
  2. Study start1 Jun 2025 (estimated)
  3. Primary completion31 Oct 2025 (estimated)
  4. Study completion30 Apr 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
This study will be a waitlist-controlled randomized pilot trial.
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06900465
Sponsor's protocol ID
2023-73
Status last verified
Mar 2025
First submitted
19 Mar 2025
Last updated
28 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: In order to protect participants' privacy, IPD will not be shared.

Questions about this trial

What is this clinical trial studying?

A study testing Caregiver Psychoeducation Group for Children and Adolescents with Emotional and Behavioral Disorders (CPG-CA) in people with Emotional and Behavioral Disorders in Children and Adolescents, run by Shanghai Mental Health Center at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 28 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Hao Yao, MD, MPH (+86 18817301628, haoyao@vip.163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Caregiver burden (time frame: Baseline (T0) and 3 months (T1)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in